Kwang‐Hyub Han

44.6k total citations · 9 hit papers
623 papers, 24.3k citations indexed

About

Kwang‐Hyub Han is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kwang‐Hyub Han has authored 623 papers receiving a total of 24.3k indexed citations (citations by other indexed papers that have themselves been cited), including 534 papers in Hepatology, 413 papers in Epidemiology and 108 papers in Surgery. Recurrent topics in Kwang‐Hyub Han's work include Liver Disease Diagnosis and Treatment (341 papers), Hepatitis B Virus Studies (274 papers) and Hepatitis C virus research (235 papers). Kwang‐Hyub Han is often cited by papers focused on Liver Disease Diagnosis and Treatment (341 papers), Hepatitis B Virus Studies (274 papers) and Hepatitis C virus research (235 papers). Kwang‐Hyub Han collaborates with scholars based in South Korea, United States and Taiwan. Kwang‐Hyub Han's co-authors include Sang Hoon Ahn, Jun Yong Park, Do Young Kim, Seung Up Kim, Chae Yoon Chon, Beom Kyung Kim, Young Nyun Park, Jinsil Seong, Ja Kyung Kim and Do Young Kim and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kwang‐Hyub Han

619 papers receiving 23.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

2006 1.1k citations Kwang‐Hyub Han et al. profile →
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

2012 834 citations Jia‐Horng Kao, Teerha Piratvisuth et al. Hepatology International profile →
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial

2015 771 citations Kwang‐Hyub Han, Kwan Sik Lee et al. profile →
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

2008 742 citations Jia‐Horng Kao, Teerha Piratvisuth et al. Hepatology International profile →
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B†,‡

2010 735 citations Kwang‐Hyub Han et al. profile →
CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

2019 497 citations Kwang‐Hyub Han et al. profile →
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

2011 457 citations Henry Lik‐Yuen Chan, Kwang‐Hyub Han et al. profile →
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

2019 361 citations Shiv Kumar Sarin, Kwang‐Hyub Han et al. profile →
A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

2020 194 citations Kwang‐Hyub Han et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kwang‐Hyub Han South Korea	72	19.0k	16.1k	3.5k	2.5k	1.9k	623	24.3k
Osamu Yokosuka Japan	63	11.6k 0.6×	10.5k 0.7×	2.9k 0.8×	2.9k 1.2×	1.8k 0.9×	668	19.0k
Michel Beaugrand France	58	13.4k 0.7×	13.2k 0.8×	3.0k 0.9×	1.4k 0.6×	1.0k 0.5×	222	18.9k
Fabio Piscaglia Italy	62	15.1k 0.8×	10.7k 0.7×	4.9k 1.4×	2.7k 1.1×	2.7k 1.4×	368	20.9k
Hiromitsu Kumada Japan	70	16.1k 0.9×	13.8k 0.9×	1.3k 0.4×	1.8k 0.7×	1.1k 0.6×	554	19.9k
Markus Peck‐Radosavljevic Austria	66	9.7k 0.5×	8.4k 0.5×	3.1k 0.9×	1.8k 0.7×	1.1k 0.6×	376	14.7k
Antonio Craxı̀ Italy	73	20.4k 1.1×	20.5k 1.3×	2.5k 0.7×	1.5k 0.6×	774 0.4×	519	27.1k
Sang Hoon Ahn South Korea	62	11.2k 0.6×	10.8k 0.7×	2.1k 0.6×	1.3k 0.5×	1.4k 0.7×	605	15.3k
Zachary Goodman United States	88	31.0k 1.6×	33.3k 2.1×	4.5k 1.3×	2.5k 1.0×	1.7k 0.9×	299	42.1k
Raymond T. Chung United States	79	13.5k 0.7×	12.9k 0.8×	1.9k 0.5×	1.5k 0.6×	855 0.4×	431	23.1k
Morris Sherman Canada	58	24.1k 1.3×	17.2k 1.1×	5.3k 1.5×	4.3k 1.7×	3.2k 1.6×	203	31.8k

Countries citing papers authored by Kwang‐Hyub Han

Since Specialization

Citations

This map shows the geographic impact of Kwang‐Hyub Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwang‐Hyub Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwang‐Hyub Han more than expected).

Fields of papers citing papers by Kwang‐Hyub Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwang‐Hyub Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwang‐Hyub Han. The network helps show where Kwang‐Hyub Han may publish in the future.

Co-authorship network of co-authors of Kwang‐Hyub Han

This figure shows the co-authorship network connecting the top 25 collaborators of Kwang‐Hyub Han. A scholar is included among the top collaborators of Kwang‐Hyub Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwang‐Hyub Han. Kwang‐Hyub Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choi, Miyoung, et al.. (2020). Rapid review of early status of COVID-19 infection in South Korea. Journal of Korean Medical Association. 63(8). 504–511. 1 indexed citations

Lee, Han Ah, Young‐Sun Lee, Beom Kyung Kim, et al.. (2020). Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma. Gut and Liver. 15(3). 420–429. 19 indexed citations

Choi, Wonsuk, Jun Namkung, Hyeongseok Kim, et al.. (2018). Serotonin signals through a gut-liver axis to regulate hepatic steatosis. Nature Communications. 9(1). 4824–4824. 124 indexed citations

Kim, Byung Seok, Yeon Seok Seo, Young Seok Kim, et al.. (2017). Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus‐related advanced fibrosis or cirrhosis. Journal of Gastroenterology and Hepatology. 33(2). 503–510. 20 indexed citations

Kim, Mi Na, Seong Gyu Hwang, Kyu Sung Rim, et al.. (2017). Validation of PAGE‐B model in Asian chronic hepatitis B patients receiving entecavir or tenofovir. Liver International. 37(12). 1788–1795. 32 indexed citations

Kim, Do Young & Kwang‐Hyub Han. (2016). Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality. Hepatology International. 10(6). 883–892. 30 indexed citations

Kim, Sung Bae, Seung Up Kim, Seung Up Kim, et al.. (2015). Outcome of adefovir add‐on lamivudine rescue therapy of up to 5 years in patients with lamivudine‐resistant chronic hepatitis B. Journal of Gastroenterology and Hepatology. 31(1). 241–247. 5 indexed citations

Calvisi, Diego F., Hyuk Moon, Silvia Ribback, et al.. (2015). Transgenic mouse model expressing P53R172H, luciferase, EGFP and KRASG12D in a single open reading frame for live imaging of tumor. Scientific Reports. 5(1). 8053–8053. 10 indexed citations

Lee, Hyun Woong, Wonseok Kang, Sang Hoon Ahn, et al.. (2014). Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen‐positive chronic hepatitis B patients. Journal of Gastroenterology and Hepatology. 29(5). 1049–1055. 5 indexed citations

10.

Lim, Seng Gee, Deepak Amarapurkar, Henry Lik‐Yuen Chan, et al.. (2014). Reimbursement policies in the Asia-Pacific for chronic hepatitis B. Hepatology International. 9(1). 43–51. 18 indexed citations

11.

Kim, Beom Kyung, Sung Hyun Ahn, Sung Hyun Ahn, et al.. (2013). Pre‐S mutations of hepatitis B virus affect genome replication and expression of surface antigens. Journal of Gastroenterology and Hepatology. 29(4). 843–850. 7 indexed citations

12.

Lee, Yong Kang, Seung Up Kim, Do Young Kim, et al.. (2013). Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization. BMC Cancer. 13(1). 5–5. 56 indexed citations

13.

Kim, Beom Kyung, Seung Up Kim, Myeong‐Jin Kim, et al.. (2012). Number of Target Lesions for EASL and Modified RECIST to Predict Survivals in Hepatocellular Carcinoma Treated with Chemoembolization. Clinical Cancer Research. 19(6). 1503–1511. 34 indexed citations

14.

Afdhal, Nezam H., Geoffrey Dusheiko, Edoardo G. Giannini, et al.. (2011). FINAL RESULTS OF ENABLE 1, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AS AN ADJUNCT FOR ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE ASSOCIATED WITH THROMBOCYTOPENIA. UCL Discovery (University College London). 12 indexed citations

15.

Sung, Joseph J.�Y., Deepak Amarapurkar, Henry LY Chan, et al.. (2010). Treatment of Chronic Hepatitis B in Asia-Pacific Countries: Is the Asia-Pacific Consensus Statement being followed?. Antiviral Therapy. 15(4). 607–616. 9 indexed citations

16.

Park, Jun Yong, Young Nyun Park, Do Young Kim, et al.. (2008). High prevalence of significant histology in asymptomatic chronic hepatitis B patients with genotype C and high serum HBV DNA levels. Journal of Viral Hepatitis. 15(8). 615–621. 68 indexed citations

17.

Lee, Keun‐Ho, Do Young ‍Kim, Ja Kyung Kim, et al.. (2006). The effect of preoperative transcatheter hepatic arterial chemoembolization in the treatment of hepatocellular carcinoma. The Korean Journal of Internal Medicine. 70(1). 17–25. 1 indexed citations

18.

Kim, Do Young, Jie‐Hyun Kim, Chae Yoon Chon, et al.. (2005). Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver International. 25(6). 1197–1201. 33 indexed citations

19.

Park, Hee Chul, Jinsil Seong, Kwang‐Hyub Han, et al.. (2002). Dose-response relationship in local radiotherapy for hepatocellular carcinoma. International Journal of Radiation Oncology*Biology*Physics. 54(1). 150–155. 220 indexed citations

20.

Kang, Shin‐Wook, Sang‐Won Lee, Kyu Hun Choi, et al.. (1996). Clinical outcome of HBsAg(+) renal allograft recipients.. PubMed. 28(3). 1653–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact